Musaffa Logo

Our certifications

Independent proof that every stock and portfolio meets halal standards.

How we screen every stock
METHODOLOGY

How we screen every stock

Our 5-step halal methodology, in 90 seconds.

HAE Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: May 26, 2026

Report Source: 2026 Annual Report

Analyst's Ratings for Haemonetics Corp (HAE)

Based on 15 analysts giving stock ratings to Haemonetics Corp in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
27
Buy
40
Hold
33
Sell
0
Strong Sell
0
Haemonetics Corp

Haemonetics Corp. Stock Analysis HAE

United States Health Care Mid Cap Report:
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. The company is headquartered in Boston, Massachusetts and currently employs 3,023 full-time employees. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). The company also offers solutions for structural heart and endovascular procedures.
Read More

Haemonetics Corp (HAE) Chart

Key Statistics of Haemonetics Corp (HAE)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$72.76$73.80

Today's Open

$73.06

Volume

625.05K

P/E Ratio (TTM)

34.13

52 Week Range

$47.32$87.32

Market Cap

2.88B

Avg. Volume

1.06M

Dividend Yield

-

Financial Metrics & Statements of Haemonetics Corp (HAE)

FAQ's for Haemonetics Corp (HAE)

  • According to Musaffa’s Shariah screening methodology, Haemonetics Corp (HAE) is currently classified as NOT HALAL as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Haemonetics Corp using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Haemonetics Corp if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Haemonetics Corp by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Haemonetics Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Haemonetics Corp on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.